BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, February 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 30, 2015
View Archived Issues
Revive Therapeutics' bucillamine receives orphan drug designation for cystinuria
Read More
Novartis reviews highlights of third quarter 2015
Read More
Vaxart awarded BARDA contract to support development of influenza tablet vaccine
Read More
Arbutus provides update on HBV pipeline
Read More
Igenica Biotherapeutics begins strategic oncology research agreement with MedImmune
Read More
Intercept reports results from phase II trial of obeticholic acid in Japanese patients with NASH
Read More
BioCision and UCSF collaborate on cell therapy for organ transplantation and diabetes
Read More
Diabetes experts review potential link between SGLT2 inhibitors and diabetic ketoacidosis
Read More
Galapagos' GLPG-1837 well tolerated in phase I trial, phase II planned
Read More
First-in-human study conducted with brain imaging agent [18F]GE-180
Read More
Allergan in discussions regarding potential business combination transaction with Pfizer
Read More
Alizé Pharma reports data from a Phase Ib trial of AZP-531 in type 2 diabetes
Read More
Beryl Therapeutics patents phenanthrolines for liver fibrosis
Read More
Daiichi Sankyo describes anti-HER3 ADCs
Read More
Takeda Pharmaceutical reports LSD1 inhibitors
Read More
Mifcare discloses MIF inhibitors
Read More
Novel ASNS gene variants identified in asparagine synthetase deficiency
Read More
Newron Pharmaceuticals to conduct sarizotan trial in patients with Rett syndrome
Read More
Tetrahedron develops organoselenium antitumor agents
Read More
ProNAi begins phase II trial of PNT-2258 in patients with Richter's transformation
Read More
PDE10A inhibitor PDM-042 shows promise for treating schizophrenia
Read More
Bardoxolone methyl shows promise for the treatment of PAH
Read More
Shionogi licenses decubitus ulcer candidate SR-0379 from FunPep
Read More
Alkermes updates on development strategy for ALKS-8700
Read More
Efficacy data from three studies on obeticholic acid
Read More
FDA approves Utibron Neohaler and Seebri Neohaler for COPD
Read More
FDA grants fast track designation to Insys' sublingual naloxone for opioid overdose
Read More
Phase I data for dengue purified inactivated vaccine
Read More
